XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]        
Revenue $ 165,285 $ 188,760 $ 345,918 $ 397,236
Cost of goods sold 121,284 135,719 250,992 273,067
Gross profit 44,001 53,041 94,926 124,169
Operating expenses        
Research and development 22,919 21,468 45,032 42,857
Selling, general and administrative 22,216 22,788 41,647 46,993
Total operating expenses 45,135 44,256 86,679 89,850
Operating income (loss) (1,134) 8,785 8,247 34,319
Other income (loss), net (472) (903) (446) (919)
Interest income (expense), net 274 (397) 503 (1,005)
Net income including noncontrolling interest (1,332) 7,485 8,304 32,395
Income tax expense 894 1,659 2,032 3,033
Net income (loss) before income (loss) from equity method investment (2,226) 5,826 6,272 29,362
Equity method investment income (loss) from equity investee (697) 511 (3,409) 3,013
Net income (loss) including noncontrolling interest $ (2,923) $ 6,337 $ 2,863 $ 32,375
Net income (loss) per common share        
Basic (in dollars per share) $ (0.10) $ 0.23 $ 0.10 $ 1.18
Diluted (in dollars per share) $ (0.10) $ 0.21 $ 0.10 $ 1.10
Weighted average number of common shares used to compute net income (loss) per share        
Basic (in shares) 27,939 27,511 27,816 27,451
Diluted (in shares) 27,939 29,576 29,830 29,499